Our in vivo model of COPD exacerbation clearly demonstrates how changes in molecular clock function and immune responses can affect morbidity and mortality, rhythms of locomotor activity, lung inflammation and small airway remodeling. The gene discussed is CLOCK; the disease is chronic obstructive pulmonary disease.